470 likes | 891 Views
ImmunoPathology I. R. Pat Bucy, MD, PhD Professor of Pathology, Microbiology, and Medicine. Type I Hypersensitivity (AKA: Anaphylactic type, immediate hypersensitivity). Due to activity of IgE Cross-linkage of Fc e resulting in mast cell degranulation Anaphylaxis - local vs systemic
E N D
ImmunoPathology I R. Pat Bucy, MD, PhD Professor of Pathology, Microbiology, and Medicine
Type I Hypersensitivity(AKA: Anaphylactic type, immediate hypersensitivity) • Due to activity of IgE • Cross-linkage of Fce resulting in mast cell degranulation • Anaphylaxis - local vs systemic • Skin test peaks in ~10 minutes • Normal function of IgE
Type II Hypersensitivity(AKA: Antibody mediated cytotoxic type) • Ab coating of cells → phagocytosis & ADCC • Ab + complement → direct lysis • Ab interaction with cell surface receptor → activation or inhibition of bioactivity
Type III Hypersensitivity(Immune complex type) • Immune complex physical chemistry and IC deposition • IC deposition in vessel walls and glomeruli • complement deposition and neutrophil activation • Skin test peaks in ~10 hours • Skin test called Arthus reaction
Type IV Hypersensitivity(Cell mediated type) • Delayed Type Hypersensitivity (DTH) - CD4+ T cell mediated macrophage and endothelial activation • Granulomatous inflammation - continual T cell drive with lack of complete M digestion of Ag • Cytolytic T Lymphocytes (CTL) - direct lysis of target cells involving TCR recognition at effector phase • NK cell activity - no specific recognition (no TCR). Require IL-2 and perhaps other cytokines. • Technical difficulties in experimental determination of cellular vs Ab mediated immune mechanisms.
Aggregation of macrophages with fibrosis Associated with chronic T cell and macrophage activation Antigen that is resistant to macrophage degradation Granulomatous Inflammation
Relationship of antibody vs cell mediated hypersensitivity • Radical difference in assay/detection methodology • Usually both are present in a strong immune response • Presence of antibody can be a marker of a specific T cell mediated lesion • Passive transfer is the key experimental approach to determine primary cause of response.
Classification SchemeMechanism vs Antigen • Classical system focuses on mechanism • Don’t know all mechanisms (especially early) • Actual disease mechanisms overlap • Alternative system focused on antigen drive • The kinetic course of antigen concentration is the key immunoregulatory entity. • Often don’t know the specific driving antigens • Infection, environmental, tumors, iatrogenic, self.
Leprosy • Two forms of disease; one bug (Mycobacterium leprae). • Tuberculoid leprosy - intense immune response with low organism load • Lepromatous leprosy - suppressed immune response with high organisms load • Different cytokine patterns in T cell response correlate with forms of disease
Contact Dermatitis • Exposure of the skin to multiple agents can cause sensitization. On repeated exposure, an eczematous eruption occurs. • Histologically, the lesion is a mononuclear infiltrate, epidermal spongiosis (intercellular edema), and vesicle formation (bullae). • Depends on ability covalently conjugate to proteins. • Exposure to poison ivy is a common example of this process.
Penicillin Allergy • Since penicillin is fairly reactive with proteins, sensitization is common. • Depending on the idiosyncratic nature of the immune response and subsequent exposure, several clinical syndromes may develop. • Formation of IgE can result in systemic anaphylaxis after penicillin therapy (particularly after intravenous administration). • Formation of IgG and drug conjugates of serum proteins (albumin) can lead to a "serum sickness" syndrome, involving fever, skin rash, lymphadenopathy, and edema. Occasionally arthritis, nephritis, and vasculitis may result. • Conjugation to red blood cells with high dose IV therapy and IgG formation can result in development of hemolytic anemia.
Recipient APC Donor APC T T Alloantigen Recognition Indirect Direct Presentation Presentation Many endogenous peptides Donor peptide Recipient T cells
Mechanisms of transplant rejection (classical) • No “real” physiologic mechanism (evolutionarily selected) • Hyperacute rejection • Acute vascular rejection • Acute cellular rejection • Chronic rejection
Mechanisms of transplant rejection • Cytotoxic damage to endothelial cells with coagulation • “DTH” in interstitium - CD4+ T cells & M activation • CTL activity on parenchymal cells (tubules, cardiomyocytes, bile ducts, hepatocytes) • T cell mediated arteritis with intimal proliferation and infarction • ADCC and NK cell activity in interstitium • Antibody mediated injury to endothelia with intimal proliferation and infarction
Clinical Monitoring of Allograft Rejection • Kidney - serum creatinine/Biopsy • Heart - Blind Biopsy • Liver - Bilirubin, transaminases/Biopsy • Lung - Pulmonary Function tests/Biopsy • Pancreas - No good method, (urinary amylase, or cytology)
Immune Complex IgE Ab T cells